Neurable is selling its own $499 Neurable One EEG headphones from October, after years of licensing its brain-sensing tech to other brands. CEO Ramses Alcaide says bringing it in-house lets the company improve the product at a much faster rate.
Perspective Coverage
3 publishers
- Builder
- Builder 23%
- Operator
- Operator 55%
- Investor
- Investor 22%
Reality
- Evidence55
- Adoption
- Not scored
- Hype gap+30
- Incentives60
- Confidence65
Distinct gut microbes mark colorectal and breast cancers diagnosed at 50 or younger
Mayo Clinic researchers tie colorectal and breast cancers diagnosed at 50 or younger to distinct gut microbes, using stool from 1,364 patients. The signals give researchers named bacteria to test next, though the data cannot yet say whether those microbes drive early disease or follow from it.
Reality
- Evidence55
- Adoption
- Not scored
- Hype gap+5
- Incentives
- Not scored
- Confidence55
UiPath's Cartographer asks your experts to record their screens to map the work
Daniel Dines told UiPath's FUSION conference that autonomous agents fail without a complete manual of how work happens. Cartographer drafts one from charts, documents and expert interviews.
Reality
- Evidence46
- Adoption31
- Hype gap+17
- Incentives83
- Confidence56
Clinicians answer the AI cure-for-cancer claim with more than 100 brain tumour types
A Melbourne oncologist told the Guardian she doubts a cure for all cancer inside 10 years, and the clinicians who said so expect the real gains in diagnostics, pathology and treatment selection. Those are steps a budget can be written against.
Reality
- Evidence62
- Adoption30
- Hype gap+58
- Incentives55
- Confidence64
Fram2's crew took usable diagnostic X-rays in orbit after four hours of training
MinXray's portable unit flew on the private Fram2 mission in March 2025, and radiologists on the ground called the crew's images clear enough to diagnose from. The report appeared in Radiology in July 2026.
Reality
- Evidence60
- Adoption22
- Hype gap+25
- Incentives55
- Confidence58
Magnetically switched nanoantennas slowed drug-resistant glioblastoma in mouse brains
The MIT Media Lab's injectable devices convert an external magnetic field into an electric field at the tumor itself, which killed chemoresistant patient cells in a dish and slowed the same tumors in mouse brains.
Reality
- Evidence56
- Adoption6
- Hype gap+27
- Incentives74
- Confidence58
buildOne report1 publisher The FDA lets one phlebotomist supervise three autonomous blood-draw robots at once
Vitestro's Aletta is the first standalone blood-draw robot authorized in the United States. What builders will actually price is the supervision ratio the FDA attached to it and the 6% of patients the machine handed back to a human.
Reality
- Evidence71
- Adoption21
- Hype gap+14
- Incentives77
- Confidence57